Castle Biosciences, Inc. (CSTL)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 26.09 |
| Open | 25.42 |
| Bid | 25.40 x 800 |
| Ask | 25.44 x 1800 |
| Day's range | 25.00 - 26.00 |
| 52-week range | 15.58 - 68.65 |
| Volume | |
| Avg. volume | 209,726 |
| Market cap | 668.47M |
| Beta (5Y monthly) | 1.14 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -2.04 |
| Earnings date | 07 Nov 2022 - 11 Nov 2022 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 50.57 |
- Business Wire
Castle Biosciences Announces Publication of Study Demonstrating the Integration of DecisionDx®-Melanoma and Clinicopathologic Factors Provides Optimized, Personalized Survival Prognoses for Patients with Cutaneous Melanoma
FRIENDSWOOD, Texas, September 23, 2022--Castle announced the publication of a study validating the performance of DecisionDx®-Melanoma’s proprietary algorithm, i31-ROR.
- Business Wire
Castle Biosciences Presents Clinical Use Scenarios for Its Diagnostic Gene Expression Profile Tests at Maui Derm NP+PA Fall 2022 Conference
FRIENDSWOOD, Texas, September 21, 2022--Castle provided a proposed framework for use of its MyPath® Melanoma and DiffDx®-Melanoma tests to help achieve personalized management plans.
- Business Wire
Castle Biosciences Presents Foundational Guideposts and Three-Year Financial Targets at 2022 Investor Day
FRIENDSWOOD, Texas, September 20, 2022--Castle Biosciences will present the Company’s foundational guideposts and three-year financial targets during its Investor Day today.
© 2022 Yahoo. All rights reserved.
